Low bone mineral density in children and adolescents with cancer

키워드

참고문헌 (61)

1. Chemaitilly W, "Endocrine late effects in childhood cancer survivors", J Clin Oncol, 36, pp.2153~2159 (2018)
2. Brignardello E, "Endocrine health conditions in adult survivors of childhood cancer : the need for specialized adult focused follow-up clinics", Eur J Endocrinol, 168, pp.465~472 (2013)
3. Hudson MM, "Clinical ascertainment of health outcomes among adults treated for childhood cancer", JAMA, 309, pp.2371~2381 (2013)
4. van Atteveld JE, "Prediction of low and very low bone mineral density among adult survivors of childhood cancer", J Clin Oncol, 37, pp.2217~2225 (2019)
5. Sala A, "Bone mineral status after treatment of malignant lymphoma in childhood and adolescence", Eur J Cancer Care (Engl), 16, pp.373~379 (2007)
6. Wasilewski-Masker K, "Bone mineral density deficits in survivors of childhood cancer : long-term followup guidelines and review of the literature", Pediatrics, 121, pp.e708~e713 (2008)
7. Lewiecki EM, "International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions", Bone, 43, pp.1115~1121 (2008)
8. Shuhart CR, "Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics", J Clin Densitom, 22, pp.453~471 (2019)
9. Gordon CM, "The determinants of peak bone mass", J Pediatr, 180, pp.261~269 (2017)
10. Heaney RP, "Peak bone mass", Osteoporos Int, 11, pp.985~1009 (2000)
11. Faulkner RA, "Size corrected BMD decreases during peak linear growth : implications for fracture incidence during adolescence", J Bone Miner Res, 21, pp.1864~1870 (2006)
12. van der Sluis IM, "Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia", J Pediatr, 141, pp.204~210 (2002)
13. Inaba H, "Bone mineral density in children with acute lymphoblastic leukemia", Cancer, 124, pp.1025~1035 (2018)
14. Al-Tonbary YA, "Bone mineral density in newly diagnosed children with neuroblastoma", Pediatr Blood Cancer, 56, pp.202~205 (2011)
15. Holzer G, "Bone mineral density in long-term survivors of highly malignant osteosarcoma", J Bone Joint Surg Br, 85, pp.231~237 (2003)
16. Ruza E, "Bone mineral density and bone metabolism in children treated for bone sarcomas", Pediatr Res, 59, pp.866~871 (2006)
17. Müller C, "Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients", BMC Musculoskelet Disord, 11, pp.287~ (2010)
18. De Nijs RN, "Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options", Minerva Med, 99, pp.23~43 (2008)
19. Mandel K, "Skeletal morbidity in childhood acute lymphoblastic leukemia", J Clin Oncol, 22, pp.1215~1221 (2004)
20. van Santen HM, "Hypogonadism in children with a previous history of cancer : endocrine management and follow-Up", Horm Res Paediatr, 91, pp.93~103 (2019)
21. Almeida M, "Estrogens and androgens in skeletal physiology and pathophysiology", Physiol Rev, 97, pp.135~187 (2017)
22. Green DM, "The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study", Pediatr Blood Cancer, 61, pp.53~67 (2014)
23. Chemaitilly W, "Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude lifetime cohort", J Clin Endocrinol Metab, 102, pp.2242~2250 (2017)
24. Chemaitilly W, "Leydig cell function in male survivors of childhood cancer : a report from the St Jude lifetime cohort study", J Clin Oncol, 37, pp.3018~3031 (2019)
25. Siegel DA, "Risk factors and surveillance for reduced bone mineral density in pediatric cancer survivors", Pediatr Blood Cancer, 64, pp.e26488~ (2017)
26. Stern JM, "Bone density loss after allogeneic hematopoietic stem cell transplantation : a prospective study", Biol Blood Marrow Transplant, 7, pp.257~264 (2001)
27. Yao S, "High prevalence of early-onset osteopenia", osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy, 2008, pp.41, 393~398
28. Taskinen M, "Bone health in children and adolescents after allogeneic stem cell transplantation : high prevalence of vertebral compression fractures", Cancer, 110, pp.442~451 (2007)
29. Choi HS, "Changes in bone health during the first year of cancer treatment in children", J Clin Densitom, 20, pp.25~31 (2017)
30. Banfi A, "High-dose chemotherapy shows a dosedependent toxicity to bone marrow osteoprogenitors : a mechanism for post-bone marrow transplantation osteopenia", Cancer, 92, pp.2419~2428 (2001)
31. Le Meignen M, "Bone mineral density in adult survivors of childhood acute leukemia : impact of hematopoietic stem cell transplantation and other treatment modalities", Blood, 118, pp.1481~1489 (2011)
32. McClune BL, "Osteoporosis after stem cell transplantation", Curr Osteoporos Rep, 11, pp.305~310 (2013)
33. Remes TM, "Bone mineral density is compromised in very long-term survivors of irradiated childhood brain tumor", Acta Oncol, 57, pp.665~674 (2018)
34. Giustina A, "Growth hormone, insulin-like growth factors, and the skeleton", Endocr Rev, 29, pp.535~559 (2008)
36. Wagner LM, "Fractures in pediatric Ewing sarcoma", J Pediatr Hematol Oncol, 23, pp.568~571 (2001)
37. Paulino AC, "Late effects of radiotherapy for pediatric extremity sarcomas", Int J Radiat Oncol Biol Phys, 60, pp.265~274 (2004)
38. Mora S, "Establishment of peak bone mass", Endocrinol Metab Clin North Am, 32, pp.39~63 (2003)
39. Tillmann V, "Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia", J Bone Miner Res, 17, pp.1073~1080 (2002)
40. Bloomhardt HM, "Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guidelinerecommended surveillance for bone health", Cancer, 126, pp.202~210 (2020)
41. te Winkel ML, "Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia", Haematologica, 95, pp.752~759 (2010)
42. Högler W, "Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia:comparison of fracture risk with the General Practice Research Database", Pediatr Blood Cancer, 48, pp.21~27 (2007)
43. Benmiloud S, "Long-term effects on bone mineral density of different therapeutic schemes for acute lymphoblastic leukemia or non-Hodgkin lymphoma during childhood", Horm Res Paediatr, 74, pp.241~250 (2010)
44. Pietilä S, "Bone mineral density is reduced in brain tumour patients treated in childhood", Acta Paediatr, 95, pp.1291~1297 (2006)
45. Kang MJ, "Risk factors for osteoporosis in long-term survivors of intracranial germ cell tumors", Osteoporos Int, 23, pp.1921~1929 (2012)
46. Ju Hyun Ahn, "Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcoma", Annals of Pediatric Endocrinology & Metabolism, 20(3), pp.150~154 (2015), 대한소아내분비학회
47. Lim JS, "Young age at diagnosis, male sex, and decreased lean mass are risk factors of osteoporosis in long-term survivors of osteosarcoma", J Pediatr Hematol Oncol, 35, pp.54~60 (2013)
48. Othman F, "Osteopenia in survivors of Wilms tumor", Int J Oncol, 20, pp.827~833 (2002)
49. Marinovic D, "Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia : a 1-year prospective study", Pediatrics, 116, pp.e102~e108 (2005)
50. Rhee SY, "Vitamin D and diabetes in Koreans: analyses based on the fourth Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2009", Diabet Med, 29, pp.1003~1010 (2012)
51. Se Won Lim, "Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density", Annals of Pediatric Endocrinology & Metabolism, 21(1), pp.21~25 (2016), 대한소아내분비학회
52. Barr RD, "Osteopenia in children with acute lymphoblastic leukemia : a pilot study of amelioration with pamidronate", Med Pediatr Oncol, 39, pp.44~46 (2002)
53. Goldbloom EB, "Osteoporosis at presentation of childhood ALL : management with pamidronate", Pediatr Hematol Oncol, 22, pp.543~550 (2005)
54. 이재민, "Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma", Blood Research, 48(2), pp.99~106 (2013), 대한혈액학회
55. Meyers PA, "Addition of pamidronate to chemotherapy for the treatment of osteosarcoma", Cancer, 117, pp.1736~1744 (2011)
56. August KJ, "The use of zoledronic acid in pediatric cancer patients", Pediatr Blood Cancer, 56, pp.610~614 (2011)
57. Carpenter PA, "Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease", Biol. Blood Marrow Transplant, 13, pp.683~690 (2007)
58. Han JW, "Poor bone health at the end of puberty in childhood cancer survivors", Pediatr Blood Cancer, 62, pp.1838~1843 (2015)
59. 최윤정, "Factors Related to Decreased Bone Mineral Density in Childhood Cancer Survivors", Journal of Korean Medical Science, 28(11), pp.1632~1638 (2013), 대한의학회
60. Lethaby C, "Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience", J Pediatr Hematol Oncol, 29, pp.613~616 (2007)
61. Wiernikowski JT, "Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study", J Oncol Pharm Pract, 11, pp.51~56 (2005)

관련 논문AI추천